Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The Commercialization Of Medical Nanotechnology For Medical Applications

D. W. Hobson
Published 2016 · Business

Save to my Library
Download PDF
Analyze on Scholarcy
Share
The potential for nanotechnology to advance medical science has been demonstrated and is increasing as the ability to manufacture and combine an ever expanding selection of nanotechnologies creates a wide variety of opportunities. Mechanisms for the commercialization of these “nanomedical” products have met with both success and failure but always with valuable lessons to apply toward advancing the future for the technology platforms. Nanotechnology applications in medicine are already having a significant impact on marketed products as well as increasing the number of commercially viable products in both pharmaceutical and medical device pipelines directed toward a wide variety of therapeutic applications. Commercial uses of nanotechnology in the development and formulation of new pharmaceuticals as well as incorporation into the designs of medical devices are increasing and hold much promise for commercial success. Regulatory agencies and legal firms worldwide are cautiously examining some aspects of many nanotechnology products toward demonstrating sustainable histories of safety and efficacy in these various medical applications. Approaches that have been successful in commercializing approved and currently marketed nanomedical products have met with many challenges and have identified and resolved critical issues that could have prevented or hindered market entry. The commercial path becoming increasingly better defined for new and developing products that hold much promise to significantly improve medicine in areas such as nanomaterial-enabled pharmaceuticals, targeted nanomolecular therapeutics and diagnostics, nanobrachytherapy agents and nano-enabled medical devices.
This paper references
10.1088/0957-4484/16/10/059
The bactericidal effect of silver nanoparticles.
J. R. Morones (2005)
10.1016/j.msec.2016.05.074
Recent advancements in nanotechnological strategies in selection, design and delivery of biomolecules for skin regeneration.
Purna Sai Korrapati (2016)
Three-Dimensional Printing Surgical Applications
Ahmad Alali (2015)
10.1016/J.NANO.2005.03.009
Protecting new ideas and inventions in nanomedicine with patents.
R. Bawa (2005)
10.1016/J.LFS.2006.12.019
Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
E. A. Leite (2007)
10.2217/nnm-2016-0017
Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
C. David (2016)
10.1016/S0167-7799(99)01335-9
Biotechnology as a route to nanotechnology
Merkle (1999)
10.1016/j.colsurfb.2016.02.053
Stimuli-responsive poly(N-isopropyl acrylamide)-co-tyrosine@gadolinium: Iron oxide nanoparticle-based nanotheranostic for cancer diagnosis and treatment.
E. Roy (2016)
10.1186/s12951-016-0193-x
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
Ewelina Piktel (2016)
10.1016/J.NANO.2004.11.010
The pathway to commercialization for nanomedicine.
T. Flynn (2005)
10.2217/17435889.2.3.351
Patents and nanomedicine.
R. Bawa (2007)
10.1126/science.1205441
FDA's Approach to Regulation of Products of Nanotechnology
M. Hamburg (2012)
10.2174/187221107780831941
Patenting of nanopharmaceuticals in drug delivery: no small issue.
L. D. du Toit (2007)
SCCP (Scientific Committee on Consumer Products) / SCHER (Scientific Committee on Health& Environment Risks) / SCENIHR (Scientific Committee on Emerging and Newly- Identified Health Risks) opinion on: Risk assessment methodologies and approaches for genotoxic and carcinogenic substances
H. Autrup (2009)
10.1111/nyas.12403
Nanomedicines: addressing the scientific and regulatory gap
S. Tinkle (2014)
10.1002/jbm.a.34584
Tissue growth into three-dimensional composite scaffolds with controlled micro-features and nanotopographical surfaces.
E. Tamjid (2013)
10.1002/wnan.28
Commercialization of nanotechnology.
D. W. Hobson (2009)
10.1259/bjr.20150207
Applications of nanoparticles for diagnosis and therapy of cancer.
S. Baetke (2015)
10.1016/j.biomaterials.2016.05.032
Nanoprobes for two-photon excitation time-resolved imaging of living animals: In situ analysis of tumor-targeting dynamics of nanocarriers.
W. Yang (2016)
10.2174/0929867323666160607103854
Recent Trends of Biocompatible and Biodegradable Nanoparticles in Drug Delivery: A Review.
D. Sundar (2016)
10.1007/BF00315408
Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris
H. C. Korting (2004)
10.1186/1743-8977-3-11
The potential risks of nanomaterials: a review carried out for ECETOC
P. Borm (2006)
10.1186/1556-276X-6-305
An antibacterial coating based on a polymer/sol-gel hybrid matrix loaded with silver nanoparticles
P. Rivero (2011)
10.1007/s11095-016-1958-5
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo (2016)
10.2174/187221008786369642
Nonobatteries: decreasing size power sources for growing technologies.
D. Lowy (2008)
10.1126/scitranslmed.3009524
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Evan Phillips (2014)
10.5167/UZH-26110
Biofilm on dental implants: a review of the literature.
K. Subramani (2009)
10.1021/ar300022h
Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening.
A. Nel (2013)
10.14797/MDCJ-8-1-2
Cardiovascular nanomedicine: a posse ad esse.
B. Godin (2012)
10.1016/j.biomaterials.2016.03.013
Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance.
J. Liu (2016)
10.1155/2016/4198790
Magnetic Nanoparticles for Targeting and Imaging of Stem Cells in Myocardial Infarction
M. Santoso (2016)
10.1016/B978-0-323-32889-0.00001-7
Nanomedicine and Tissue Engineering
C. Sudhakar (2015)
10.1016/0263-7863(95)00064-X
A new framework for determining critical success/failure factors in projects
W. Belassi (1996)
10.1016/j.tibtech.2010.07.006
Nanosilver as a new generation of nanoproduct in biomedical applications.
K. Chaloupka (2010)
10.1287/MKSC.1.1.57
Maximum Likelihood Estimation for an Innovation Diffusion Model of New Product Acceptance
David C. Schmittlein (1982)
10.1016/j.ijpharm.2012.02.042
Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.
Sonali V Kapse (2012)
10.1038/nmat4586
Directed migration of cancer cells by the graded texture of the underlying matrix
Jinseok Park (2016)
10.4155/ppa.11.4
The impact of effective patents on future innovations in nanomedicine.
Rita Bosetti (2012)
10.1088/0957-4484/25/37/372501
Has nanomedicine lived up to its promise?
S. Venkatraman (2014)
10.1563/AAID-JOI-D-13-00232
Nanocrystalline hydroxyapatite-based material already contributes to implant stability after 3 months: a clinical and radiologic 3-year follow-up investigation.
S. Ghanaati (2014)
10.4155/ppa.14.47
Nanoparticles applied to antineoplastic agents: a patent landscape.
I. Fierro (2014)
10.7150/thno.16153
Progress in the Development of Nanotheranostic Systems
H. Cui (2016)
10.17219/acem/60879
The Nanopharmacology and Nanotoxicology of Nanomaterials: New Opportunities and Challenges.
A. Radomska (2016)
10.2174/187221012798109309
Trends in nanotechnology patents applied to the health sector.
A. M. S. Antunes (2012)
10.1002/JPS.2600780613
Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice.
A. Rolland (1989)
10.1016/S0939-6411(01)00188-6
Biodegradable polymer nanocapsules containing a sunscreen agent: preparation and photoprotection.
R. Alvarez-Román (2001)
10.1088/0957-4484/14/8/312
An integrated optical interferometric nanodevice based on silicon technology for biosensor applications
Francisco Prieto (2003)
10.1080/10408440601177780
Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety
G. Nohynek (2007)
Guidance on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices
A. Proykova (2014)
10.1016/j.actbio.2013.11.002
A novel therapeutic design of microporous-structured biopolymer scaffolds for drug loading and delivery.
B. Dorj (2014)
10.1515/hsz-2011-0237
At the cutting edge: applications and perspectives of laser nanosurgery in cell biology
Paolo Ronchi (2012)
10.1097/01.rli.0000156195.74967.47
A New Polymer Concept for Coating of Vascular Stents Using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to Reduce Thrombogenicity and Late In-Stent Stenosis
G. Richter (2005)
10.1016/j.aca.2015.11.050
New advances in electrochemical biosensors for the detection of toxins: Nanomaterials, magnetic beads and microfluidics systems. A review.
Laia Reverté (2016)
10.1088/0957-4484/24/43/432002
Design strategies of hybrid metallic nanoparticles for theragnostic applications.
J. Gautier (2013)
10.1016/j.ijpharm.2016.05.015
Dealing with nanosafety around the globe-Regulation vs. innovation.
M. Wacker (2016)
10.1016/j.addr.2012.09.038
Cancer nanomedicines: so many papers and so few drugs!
Vincent J Venditto (2013)
10.2147/IJN.S63064
Toxicology of antimicrobial nanoparticles for prosthetic devices
R. E. Nuñez-Anita (2014)
10.1016/j.ejpb.2015.03.018
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Edgar Pérez-Herrero (2015)
10.1016/j.bios.2015.11.083
Electrochemical biosensors based on nanofibres for cardiac biomarker detection: A comprehensive review.
B. Rezaei (2016)
10.1089/WOUND.2014.0586
Choosing a Wound Dressing Based on Common Wound Characteristics.
Ganary Dabiri (2016)
10.1615/CRITREVTHERDRUGCARRIERSYST.2015011645
Nanotechnology-Based Photodynamic Therapy: Concepts, Advances, and Perspectives.
Tarun Garg (2015)
10.1016/j.nano.2014.02.014
Intestinal absorption of insulin nanoparticles: contribution of M cells.
M. A. Lopes (2014)
10.1021/mp300320d
Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
S. Jain (2012)
10.1046/j.1467-2494.2000.00009.x
Skin penetration and stabilization of formulations containing microfine titanium dioxide as physical UV filter
Bennat (2000)
10.1016/j.addr.2016.05.013
Graphene-based nanomaterials for bioimaging.
J. Lin (2016)
10.1177/0885328215570103
Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits
Franziska Duda (2015)
10.1002/wnan.1194
Changes in cardiopulmonary function induced by nanoparticles.
Erin E Mann (2012)
10.1504/IJBRA.2012.045954
Application of nanotechnology in cancer: a review
S. Kolhe (2012)
10.1021/acs.bioconjchem.5b00607
Transforming Nanomedicines From Lab Scale Production to Novel Clinical Modality.
Dalit Landesman-Milo (2016)
10.1166/JNN.2015.9032
High-Content Screening for Assessing Nanomaterial Toxicity.
Lingling Huo (2015)
10.3390/ijms16012099
Antimicrobial Polymers with Metal Nanoparticles
H. Palza (2015)
10.1007/s11095-015-1706-2
Phytantriol Based “Stealth” Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel
S. Jain (2015)
10.1002/wnan.1322
Therapeutic gold, silver, and platinum nanoparticles.
M. Yamada (2015)
10.1517/17425247.1.1.141
Particle uptake by Peyer’s patches: a pathway for drug and vaccine delivery
Monjed Shakweh (2004)
10.1002/wnan.29
Prospects and developments in cell and embryo laser nanosurgery.
Vikram Kohli (2009)
10.1021/acsnano.6b02878
Efficient Targeting of Adipose Tissue Macrophages in Obesity with Polysaccharide Nanocarriers.
Liang Ma (2016)
10.1166/JBN.2012.1457
Nanocoating of titanium implant surfaces with organic molecules. Polysaccharides including glycosaminoglycans.
K. Gurzawska (2012)
10.1088/0957-4484/27/29/29LT01
A primary battery-on-a-chip using monolayer graphene.
R. M. Iost (2016)
10.1080/17425247.2016.1198773
Safety assessment of nanoparticles for drug delivery by means of classic in vitro assays and beyond
Stefan Lorscheidt (2016)
10.1002/BJS.10188
Three-dimensional printing and the surgeon.
A. Mel (2016)
10.1016/j.jconrel.2014.06.005
Issues and concerns in nanotech product development and its commercialization.
I. P. Kaur (2014)
10.1002/wnan.1409
Dendrimer-based nanocarriers: a versatile platform for drug delivery.
Hao-jui Hsu (2017)
10.1007/s00204-016-1701-3
Assessment of the oxidative potential of nanoparticles by the cytochrome c assay: assay improvement and development of a high-throughput method to predict the toxicity of nanoparticles
M. Delaval (2016)
10.1089/WOUND.2013.0506
Traditional Therapies for Skin Wound Healing.
Rúben F. Pereira (2016)
10.1016/j.drup.2011.01.003
Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Alina Shapira (2011)
10.12968/JOWC.2011.20.11.543
Silver and nanoparticles of silver in wound dressings: a review of efficacy and safety.
L. Wilkinson (2011)
Understanding Nanomedicine: An Introductory Textbook
Rob Burgess (2012)
10.1166/JNN.2005.426
Optical nanobiosensor for monitoring an apoptotic signaling process in a single living cell following photodynamic therapy.
P. Kasili (2005)
10.1016/j.bjps.2015.08.028
Nanotechnology and regenerative therapeutics in plastic surgery: The next frontier.
A. Tan (2016)
10.1201/B11619-6
Nanotechnology Patent Procurement and Litigation in Europe
Hanna R. Laure´n (2012)
10.1021/acs.molpharmaceut.5b00281
Enhanced Antitumor Efficacy and Reduced Toxicity of Docetaxel Loaded Estradiol Functionalized Stealth Polymeric Nanoparticles.
S. Jain (2015)
10.2174/1389201015666140915150826
Therapeutic nanosystems for oral administration of insulin.
F. A. do Carmo (2014)
10.1166/JBN.2016.2220
Techniques for Investigating Molecular Toxicology of Nanomaterials.
Y. Wang (2016)
10.1039/C5TB00450K
Nanocoating for biomolecule delivery using layer-by-layer self-assembly.
M. Keeney (2015)
10.1007/S12668-012-0047-4
Nanotechnology-Based Biosensors and Diagnostics: Technology Push versus Industrial/Healthcare Requirements
S. K. Vashist (2012)
10.1002/AIC.10087
Nanoscale Science and Engineering: Unifying and Transforming Tools
M. Roco (2004)
A nanotechnology-based delivery system: Nanobots. Novel vehicles for molecular medicine.
T. Jacob (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar